This revised guidance from the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) describes internationally accepted principles and practices in the design and conduct of clinical studies of drug and biological products. The guidance incorporates the most current concepts achieving fit-for-purpose data quality as one of the essential considerations for all clinical trials.
ICH E8(R1) General Considerations for Clinical Studies
Previous
Previous
FDA Responses to Good Clinical Practice Inquiries
Next
Next